Junshik Hong

27PUBLICATIONS

89CO-AUTHORS

Regenerative medicine (incl. stem cells)Labour, migration and developmentHaematological tumoursMedical virologyCancer therapy (excl. chemotherapy and radiation therapy)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (27)

Sort by Publication Date:

|Jun 02, 2026

Selinexor Plus Ruxolitinib in Janus Kinase Inhibitor-Naïve Myelofibrosis: Phase III SENTRY Trial.

|Mar 11, 2026

Persistent and emerging cancer risks after migration: Evidence from North and South Korean cohorts.

Junshik Hong, Kyeong Jin Kim, Jimi Choi

|Dec 25, 2025

Real-world experience with tisagenlecleucel for the treatment of relapsed or refractory diffuse large B-cell lymphoma in Korea.

Dong Hyun Kim, Soyean Kwon, Seungah Cha

|Dec 04, 2025

Clinical Outcomes of Low-Grade Cytomegalovirus DNAemia in Hematopoietic Stem Cell Transplantation Recipients Receiving Letermovir Prophylaxis.

Jung Soo Son, Eun-Jeong Jeong, Hyeon Jae Jo

|Jul 14, 2025

Azacitidine followed by R-GDP in transplant-ineligible relapsed/refractory diffuse large B-cell lymphoma: preliminary results from a multicenter, phase II study.

Dong Hyun Kim, Jee Hyun Kong, Junshik Hong

|Jun 25, 2025

The role of ASXL1, SRSF2, and EZH2 mutations in chromatin dysregulation of myelodysplastic neoplasia and acute myeloid leukemia.

Hosang Yu, Junshik Hong, Dong-Yeop Shin

Pageof 5

Frequent Collaborators

Sung-Soo Yoon

Soo-Mee Bang

Dong-Yeop Shin

Ja Min Byun

Inho Kim

Youngil Koh

Dong Hyun Kim

Sang-A Kim

Ho-Young Yhim

Youngil Koh

Frequent Collaborators

Sung-Soo Yoon

Soo-Mee Bang

Dong-Yeop Shin

Ja Min Byun